Julianne Bergdale
Obstetrics & Gynecology · Phoenix, AZNPI 1174517361
Payments from drug & device makers
Across 97 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$315
- Bayer$153
- Exeltis, USA Inc.$142
- Hologic Sales And Service, LLC$126
- Daiichi Sankyo Inc.$102
- Organon$89
- plus $952 from 28 others
What the payments were for
- Food & beverage$1,85299%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $315 |
| Bayer | 9 | $153 |
| Exeltis, USA Inc. | 9 | $142 |
| Hologic Sales And Service, LLC | 6 | $126 |
| Daiichi Sankyo Inc. | 5 | $102 |
| Organon | 5 | $89 |
| Evofem Biosciences, Inc. | 5 | $75 |
| Mayne Pharma Commercial LLC | 3 | $60 |
| Myriad Women's Health, Inc. | 1 | $60 |
| Shield Therapeutics Inc | 1 | $54 |
| Therapeuticsmd, Inc. | 3 | $52 |
| Aspira Women's Health Inc | 2 | $46 |
| Millicent US Inc | 2 | $44 |
| Biogen | 2 | $41 |
| Channel Medsystems, Inc. | 1 | $39 |
| Novo Nordisk | 2 | $38 |
| Amgen | 2 | $37 |
| Pfizer | 2 | $37 |
| BD | 2 | $36 |
| Myovant Sciences Inc. | 2 | $35 |
| Seqirus USA Inc | 2 | $33 |
| Merck | 2 | $32 |
| Alfasigma USA, Inc. | 2 | $32 |
| Avion Pharmaceuticals | 2 | $30 |
| Avanos Medical | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Mylan Pharmaceuticals Inc. | 1 | $18 |
| Exact Sciences | 1 | $18 |
| Sage Therapeutics, LLC | 1 | $17 |
| Agile Therapeutics, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Scynexis, Inc. | 1 | $12 |
How this compares
$1,879 in reported general payments places this provider in the 70th percentile of 757 obstetrics & gynecology providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 102 | $5,424 |
| PremproEstrogen,con/M-Progest Acet | 16 | $3,864 |
| ValacyclovirValacyclovir Hcl | 24 | $1,533 |
| Estradiol (Once Weekly)Estradiol | 27 | $1,333 |
| ProgesteroneProgesterone, Micronized | 41 | $817 |
| Medroxyprogesterone Acetate | 12 | $217 |
| Escitalopram Oxalate | 11 | $92 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPrempro | $37 | $3,86416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 757 obstetrics & gynecology providers in Arizona.
Other obstetrics & gynecology in Phoenix
- Charles PlimptonPhoenix$7.9M
- Valerie Sorkin WellsPhoenix$5M
- Nicholas BujakPhoenix$662K
- Steven NelsonPhoenix$159K
- Bj HoPhoenix$134K
- Dean CoonrodPhoenix$119K
- Chijioke SoribePhoenix$117K
- Heather ZechmanPhoenix$92K
- David GlassmanPhoenix$90K
- Meghan MacclearyPhoenix$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.